Glucose control
Pro Research Analysisby 
Searched over 200M research papers for "glucose control"
Glucose Control in Diabetes Management
Continuous Glucose Monitoring (CGM) for Improved Glycemic Control
Continuous glucose monitoring (CGM) has emerged as a pivotal tool in managing diabetes, particularly for patients with type 1 diabetes. Studies have shown that CGM can significantly improve glycemic control by providing real-time data on glucose levels, allowing for timely interventions. For instance, a study involving the Guardian RT device demonstrated that patients using CGM continuously or biweekly had better glycemic control compared to those relying solely on self-monitoring of blood glucose (SMBG)1. This improvement is attributed to the ability of CGM to alert users to hypo- and hyperglycemic events, thereby enabling more precise insulin adjustments.
Meta-Analysis of CGM Efficacy
A comprehensive meta-analysis of randomized controlled trials (RCTs) further supports the benefits of CGM. The analysis revealed that CGM usage leads to modest reductions in HbA1c levels, increased time in target glucose range (TIR), and decreased time above and below the target range (TAR and TBR, respectively)3. These benefits were consistent across different types of diabetes and methods of insulin delivery, underscoring the versatility and effectiveness of CGM in diverse patient populations.
Intensive Glucose Control in Type 2 Diabetes
Intensive glucose control has been shown to reduce the risk of microvascular complications in patients with type 2 diabetes. A meta-analysis of large-scale RCTs found that more intensive glucose control significantly reduced the incidence of kidney and eye events, although it did not have a significant impact on nerve events4. This highlights the importance of maintaining stringent glucose levels to prevent long-term complications in type 2 diabetes.
Glucose Control in Critically Ill Patients
The optimal glucose target for critically ill patients remains a topic of debate. Studies have shown mixed results regarding the benefits of intensive glucose control in the ICU. For example, one large international trial found that intensive glucose control increased mortality compared to conventional glucose control5. Another study, the Glucontrol trial, also reported no significant benefit of intensive insulin therapy and noted a higher incidence of hypoglycemia6. These findings suggest that while tight glucose control can be beneficial, it must be carefully managed to avoid adverse outcomes.
Technological Advances in Glucose Regulation
Innovative approaches to glucose regulation, such as the Automatic Regulation of Glucose (ARG) algorithm, are being developed to simplify diabetes management. The ARG algorithm, which does not require carbohydrate counting, has shown promising results in maintaining safe blood glucose levels through a combination of advanced control techniques10. This technology represents a significant step forward in automating diabetes care and reducing the burden on patients.
Conclusion
Effective glucose control is crucial for managing diabetes and preventing complications. Continuous glucose monitoring has proven to be a valuable tool in achieving better glycemic control, particularly in type 1 diabetes. Intensive glucose control can reduce microvascular complications in type 2 diabetes, although its application in critically ill patients requires careful consideration. Advances in technology, such as the ARG algorithm, offer new possibilities for simplifying and improving diabetes management. As research continues, these tools and strategies will play an increasingly important role in optimizing glucose control for patients with diabetes.
Sources and full results
Most relevant research papers on this topic
Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring.
The Guardian RT real-time glucose monitor improves glycemic control in poorly controlled type 1 diabetes patients compared to conventional self-monitoring.
RCT
Rigorous Journal
Highly CitedMeasurements of Glucose Control
Measurements of glucose control are crucial for evaluating new treatments and understanding the role of glycemia on diabetes degenerative complications.
Highly CitedEffects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials
Continuous glucose monitoring improves glycemic control by expanding time in target range and decreasing time below, above, and glucose variability in both type 1 and type 2 diabetes patients.
Meta-AnalysisRigorous JournalHighly CitedEffects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials.
Intensive glucose control over 5 years reduced kidney and eye events in adults with type 2 diabetes, but not nerve events.
Meta-AnalysisHighly CitedIntensive versus conventional glucose control in critically ill patients.
Intensive glucose control increased mortality in critically ill patients, while a blood glucose target of 180 mg or less per deciliter resulted in lower mortality.
RCT
Large Human TrialHighly CitedA prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study
Intensive insulin therapy (target 4.4-6.1 mmol/L) showed no clinical benefit and increased hypoglycemic risk compared to a 7.8-10.0 mmol/L target in adult ICU patients.
RCTLarge Human TrialHighly CitedContinuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study.
Continuous glucose monitoring in pediatric patients with type 1 diabetes improves metabolic control and provides new insight and increased motivation.
RCTHighly CitedGlucose control in the ICU.
Tight glucose control is well-tolerated and effective in critically ill patients receiving early parenteral nutrition, but its benefits in the absence of early parenteral nutrition remain unclear.
Literature ReviewBlood glucose control by a model predictive control algorithm with variable sampling rate versus a routine glucose management protocol in cardiac surgery patients: a randomized controlled trial.
The eMPC algorithm is more effective and safer than the routine glucose management protocol in maintaining euglycemia in cardiac surgery patients.
RCTHighly Cited